Search results
6 days ago · Namita Thapar, the Executive Director of Emcure Pharmaceuticals, is set to earn approximately Rs 127.87 crore from the company's upcoming Initial Public Offering (IPO).
4 days ago · The SEHER program was launched by Ms. Anna Roy, Mission Director, Women Entrepreneurship Platform (WEP) and Principal Economic Adviser, NITI Aayog in the presence of Mr. Jitendra Asati, Director (Financial Inclusion), Department of Financial Services (DFS), Ministry of Finance; Mr. Sunil Mehta, Chief Executive, Indian Banks’ Association (IBA ...
8 hours ago · The selling shareholders in the OFS include promoters Satish Ramanlal Mehta, Sunil Rajanikant Mehta, Namita Vikas Thapar, and Samit Satish Mehta. Furthermore, shares in the OFS will be offloaded ...
1 day ago · The Women Entrepreneurship Platform (WEP) and TransUnion CIBIL have launched SEHER, a credit education programme to enhance financial literacy and business skills among women entrepreneurs.
11 hours ago · Investors who offloaded their stakes under the OFS included promoters Namita Thapar, Satish Ramanlal Mehta, Sunil Rajanikant Mehta, and Samit Satish Mehta, as well as BC Investments IV Ltd, an affiliate of the US-based private equity major Bain Capital. Shark Tank fame Namita Thapar is expected to make around ₹ 127 crore through the issue ...
6 days ago · 3 Min Read. The initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on Wednesday, July 3. The three-day bidding process will conclude on July 5. NSE. Ahead of the issue opening, shares of the company are commanding a premium of ₹290 in the unlisted market.
Jul 1, 2024 · Samit Mehta, Sunil Mehta, Namita Thapar, and Satish Ramanlal Mehta are among the company's promoters.
